SKU: 102-27504-RB
Anti-GSK3 alpha (GSK3A) (N-term) Antibody
Blue Ice
Specifications
| Specification | Details |
|---|---|
| Species Reactivity | Human |
| Application | WB, IHC-P |
| Label | Unconjugated |
| Gene ID | 2931 |
| Accession No. | P49840, P18265, Q2NL51 |
| Immunogen | This GSK3A antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 76~15 amino acids from the N-terminal region of human GSK3A. |
| Background | Glycogen synthase kinase 3-alpha (GSK3A)is a multifunctional protein serine kinase implicated in the control of several regulatory proteins including glycogen synthase and transcription factors. It also plays a role in the WNT and PI3K signaling pathways. Under resting conditions GSK3A and its homologs are highly phosphorylated at tyr279 in the phosphorylation loop. Constitutive phosphorylation of this tyrosine is important for kinase activity. Dephosphorylation of tyr279 after mitogen activation is accompanied by kinase inactivation. PKA as well as PI3K-activated PKB inactivate GSK3A by phosphorylation at ser21. Lysophosphatidic acid primarily utilizes a PKC-dependent pathway to modulate GSK3 and certain growth factors (e.g., PDGFB), which control GSK3 mainly through PIK3-PKB, are able to regulate GSK3 through an alternative, redundant PKC pathway. In mice expressing familial AD-associated mutations in APP and PSEN1, lithium reduced the levels of beta-amyloid peptides GSK3A also phosphorylates the tau protein, the principal component of neurofibrillary tangles in AD, and suggested that inhibition of GSK3A may offer a new therapeutic approach to AD. |
| Primary / Secondary | Primary Antibody |
| Isotype | Rabbit Ig |
| Clone Name | RB3817/3818 |
| Clonality | Polyclonal |
| Host | Rabbit |
Catalog Number
102-27504-RB
Name
Anti-GSK3 alpha (GSK3A) (N-term) Antibody
Price(400 ul)
Pack Size
400 ul